title: A review of the clinical effectiveness and cost-effectiveness of routine anti-D prophylaxis for pregnant women who are rhesus-negative.
authors.affiliation: School of Health and Related Research, University of Sheffield, UK.
authors.forename: J
authors.initials: J
authors.lastname: Chilcott
authors.forename: M
authors.initials: M
authors.lastname: Lloyd Jones
authors.forename: J
authors.initials: J
authors.lastname: Wight
authors.forename: K
authors.initials: K
authors.lastname: Forman
authors.forename: J
authors.initials: J
authors.lastname: Wray
authors.forename: C
authors.initials: C
authors.lastname: Beverley
authors.forename: P
authors.initials: P
authors.lastname: Tappenden
mesh_terms: D003362:Cost-Benefit Analysis; D004899:Erythroblastosis, Fetal / Q000191:economics / Q000276:immunology / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007518:Isoantibodies / Q000276:immunology; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000191:economics / Q000517:prevention & control*; D012204:Rh-Hr Blood-Group System / Q000276:immunology; D018029:Rho(D) Immune Globulin / Q000191:economics* / Q000627:therapeutic use*; D006113:United Kingdom
chemical_list: D007518:Isoantibodies; C061961:RHO(D) antibody; D012204:Rh-Hr Blood-Group System; D018029:Rho(D) Immune Globulin